Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A method for forensic-ready intrusion detection using explainable learning, prediction-aware graph modeling, and counterfactual analysis.

MethodsX·2026
Same author

ConvGeM-next: a deep learning framework for plant disease detection.

Frontiers in plant science·2026
Same author

RETRACTED: Srivastava et al. Match-Level Fusion of Finger-Knuckle Print and Iris for Human Identity Validation Using Neuro-Fuzzy Classifier. <i>Sensors</i> 2022, <i>22</i>, 3620.

Sensors (Basel, Switzerland)·2026
Same author

Stacking Deep Neural Networks to Detect Multiple Types of Cardiac Arrhythmias.

IEEE journal of biomedical and health informatics·2026
Same author

Quality of Drug Allergy Documentation in a Resource-Limited Paper-Based Hospital in Pakistan: Audit of Concordance and Completeness.

Healthcare (Basel, Switzerland)·2026
Same author

Ergodicity and regime recoverability in finite Markov-modulated random walks.

Scientific reports·2026

Related Experiment Video

Updated: Feb 17, 2026

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.9K

Explainable bidirectional encoder representations from image transformers for Alzheimer's disease prediction.

Sheikh Muhammad Saqib1, Mona A Alkhattabi2, Muhammad Amir Khan3

  • 1Department of Computing and Information Technology, Gomal University, Dera Ismail Khan, Pakistan.

Digital Health
|February 16, 2026
PubMed
Summary

This study introduces an AI framework using Bidirectional-Encoder representations from Image Transformers (BEiT) for accurate Alzheimer's disease (AD) classification from MRI scans. The model achieved high accuracy, aiding early diagnosis and intervention strategies.

Keywords:
Alzheimer's disease (AD)artificial intelligence (AI)bidirectional-encoderexplainable AI (XAI)local interpretable model-agnostic explanations (LIME)

More Related Videos

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.4K

Related Experiment Videos

Last Updated: Feb 17, 2026

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.9K
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.4K

Area of Science:

  • Artificial Intelligence in Medicine
  • Neuroimaging Analysis
  • Machine Learning for Diagnostics

Background:

  • Alzheimer's disease (AD) causes progressive neurological decline, impacting cognition, behavior, and quality of life for patients and caregivers.
  • Early and precise diagnosis of AD is crucial for implementing effective intervention strategies.
  • Artificial intelligence (AI) shows significant promise in medical imaging for AD detection and classification.

Purpose of the Study:

  • To develop and evaluate an explainable transformer-based AI framework for automated AD stage classification.
  • To leverage Bidirectional-Encoder representations from Image Transformers (BEiT) for analyzing magnetic resonance imaging (MRI) brain scans.
  • To enhance the precision of AD diagnosis through advanced machine learning techniques.

Main Methods:

  • Utilized a dataset of 8511 MRI brain images across three diagnostic groups: mild, moderate, and no impairment.
  • Employed BEiT as a feature extractor within the proposed AI framework.
  • Addressed class imbalance using a Wasserstein generative adversarial network with gradient penalty for synthetic MRI image generation and data augmentation.

Main Results:

  • Achieved outstanding classification accuracy of 96%.
  • Reported high F1-scores: 0.94 (mild AD), 1.00 (moderate AD), and 0.95 (no AD).
  • Demonstrated strong performance with a mean absolute error of 0.0727, Cohen's kappa of 0.9451, Matthews correlation coefficient of 0.9455, and Hamming loss of 0.0365.

Conclusions:

  • The developed explainable transformer-based framework demonstrates high efficacy in classifying AD stages from MRI scans.
  • The AI model's performance indicates its potential as a valuable tool for early and accurate Alzheimer's disease diagnosis.
  • The study highlights the significant role of advanced AI techniques, like BEiT, in neuroimaging for neurodegenerative disease assessment.